Facile one-pot synthesis of hollow mesoporous fluorescent Gd2O3:Eu/calcium phosphate nanospheres for simultaneous dual-modal imaging and pH-responsive drug delivery
Source abstract
Abstract
Abstract The hollow nanospheres (NSs) composed of lanthanides have become a hot topic owing to their uncommon magnetic and optical properties arising from the 4f electrons. However, only a few novel methods have been developed for effectively integrating small calcium phosphate (CaP) nanoparticles and rare earth oxide drug carriers into an individual hollow mesoporous nanosphere. Herein, we report a facile, reproducible, room-temperature solution method to prepare multifunctional fluorescent hollow mesoporous Gd2O3:Eu/CaP (designated as HM-Gd2O3:Eu/CaP) NSs by using polyacrylic acid calcium (PAA-Ca) as a template. The excellent luminescent property and obvious T1-enhancement effect as well as the HM structure endow the HM-Gd2O3:Eu/CaP NSs with the capacity of simultaneous dual-modal fluorescence, magnetic resonance (MR) imaging and drug delivery. The nanocontainer-functionality of the HM-Gd2O3:Eu/CaP NSs is further validated upon filling with the anti-cancerogenic agent doxorubicin (drug-loading capacity is 749 μg mg−1). In addition, the HM-Gd2O3:Eu/CaP NSs display excellent pH-responsive and sustained drug release property. In vitro cell cytotoxicity tests verify the HM-Gd2O3:Eu/CaP NSs have good biocompatibility when the concentration ≤25 mg mL−1. Taken together, the results suggested that the HM-Gd2O3:Eu/CaP NSs can be applied as fluorescence and MR dual-modal imaging contrast agents and drug delivery vehicles.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Luminescence Properties of Advanced Materials · Metal-Organic Frameworks: Synthesis and Applications · Nanocluster Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (55)
Show source-provided references
1. Hydrophobic anticancer drug delivery by a 980 nm laser-driven photothermal vehicle for efficient synergistic therapy of cancer cells in vivo10.1002/adma.201301232 ↗
2. Immunolabeling and nir-excited fluorescent imaging of Hela cells by using NaYF4:Yb,Er upconversion nanoparticles10.1021/nn900491j ↗
3. Facile and scalable synthesis of novel spherical Au nanocluster assemblies@polyacrylic acid/calcium phosphate nanoparticles for dual-modal imaging-guided cancer chemotherapy10.1002/smll.201403517 ↗
4. Near-infrared light-responsive nanomaterials in cancer therapeutics10.1039/C4CS00011K ↗
5. Synthetic micro/nanomotors in drug delivery10.1039/C4NR03124E ↗
6. Multifunctional tumor pH-sensitive self-assembled nanoparticles for bimodal imaging and treatment of resistant heterogeneous tumors10.1021/ja4108287 ↗
7. Plasmonic vesicles of amphiphilic nanocrystals: optically active multifunctional platform for cancer diagnosis and therapy10.1021/acs.accounts.5b00059 ↗
8. Lanthanides: applications in cancer diagnosis and therapy10.1021/acs.jmedchem.5b01975 ↗
9. Dual-targeted multifunctional nanoparticles for magnetic resonance imaging guided cancer diagnosis and therapy10.1021/acsami.6b16486 ↗
10. Two-dimensional nanomaterials for cancer nanotheranostics
11. Pd nanosheet-covered hollow mesoporous silica nanoparticles as a platform for the chemo-photothermal treatment of cancer cells10.1002/smll.201200962 ↗
12. Gold nanoshelled liquid perfluorocarbon nanocapsules for combined dual modal ultrasound/CT imaging and photothermal therapy of cancer10.1002/smll.201302252 ↗
13. Smart probe for tracing cancer therapy: selective cancer cell detection, image-guided ablation, and prediction of therapeutic response in situ10.1002/smll.201501498 ↗
14. Carbon nanodots featuring efficient FRET for real-time monitoring of drug delivery and two-photon imaging10.1002/adma.201303124 ↗
15. Silicon-nanowire-based nanocarriers with ultrahigh drug-loading capacity for in vitro and in vivo cancer therapy10.1002/anie.201206737 ↗
16. Black phosphorus nanosheets as a robust delivery platform for cancer theranostics10.1002/adma.201603276 ↗
17. Gold nanorods coated with mesoporous silica shell as drug delivery system for remote near infrared light-activated release and potential phototherapy10.1002/smll.201402145 ↗
18. Visible-light-triggered drug release from TiO2 nanotube arrays: a controllable antibacterial platform10.1002/ange.201508710 ↗
19. Electrospinning of polymeric nanofibers for drug delivery applications10.1016/j.jconrel.2014.04.018 ↗
20. Synthesis of CaCO3 nanobelts for drug delivery in cancer therapy10.1186/s11671-015-0948-6 ↗
21. Highly hydrophilic luminescent magnetic mesoporous carbon nanospheres for controlled release of anticancer drug and multimodal imaging10.1021/acs.langmuir.5b03898 ↗
22. Facile preparation of silicon hollow spheres and their use in electrochemical capacitive energy storage10.1039/c2cc17083c ↗
23. Pt hollow nanospheres: facile synthesis and enhanced electrocatalysts10.1002/anie.200352956 ↗
24. Large-scale production of self-assembled SnO2 nanospheres and their application in high-performance chemiluminescence sensors for hydrogen sulfide gas10.1039/b617114a ↗
25. Nanoengineering of particle surfaces10.1002/1521-4095(200101)13:1<11::AID-ADMA11>3.0.CO;2-N ↗
26. Facile fabrication of rare-earth-doped Gd2O3 hollow spheres with upconversion luminescence, magnetic resonance, and drug delivery properties10.1021/jp209055t ↗
27. General synthetic strategy for high-yield and uniform rare-earth oxysulfate (RE2O2SO4, RE = La, Pr, Nd, Sm, Eu, Gd, Tb, Dy, Y, Ho, and Yb) hollow spheres10.1039/c2ra21007j ↗
28. Hollow micro-/nanostructures: synthesis and applications10.1002/adma.200800854 ↗
29. Controlled fabrication and optical properties of uniform CeO2 hollow spheres10.1039/c3ra22636k ↗
30. Uniform magnesium silicate hollow spheres as high drug-loading nanocarriers for cancer therapy with low systemic toxicity10.1039/c3dt50659b ↗
31. Controllable synthesis of SnO2@C yolk-shell nanospheres as a high-performance anode material for lithium ion batteries10.1039/C3NR06452B ↗
32. Syntheses and biomedical applications of hollow micro-/nano-spheres with large-through-holes10.1039/C5CS00695C ↗
33. Monodisperse core-shell structured up-conversion Yb(OH)CO3@YbPO4:Er3+ hollow spheres as drug carriers10.1016/j.biomaterials.2011.02.026 ↗
34. Hollow structured upconversion luminescent NaYF4:Yb3+, Er3+ nanospheres for cell imaging and targeted anti-cancer drug delivery10.1016/j.biomaterials.2012.11.004 ↗
35. Hollow structured SrMoO4:Yb3+, Ln3+ (Ln = Tm, Ho, Tm/Ho) microspheres: tunable up-conversion emissions and application as drug carriers10.1039/c3tb00377a ↗
36. Lanthanide nanoparticles: from design toward bioimaging and therapy10.1021/acs.chemrev.5b00091 ↗
37. The facile synthesis of hollow Au nanoflowers for synergistic chemo-photothermal cancer therapy10.1039/C5CC05676D ↗
38. Optical imaging and anticancer chemotherapy through carbon dot created hollow mesoporous silica nanoparticles10.1016/j.actbio.2017.03.054 ↗
39. Dual-modality in vivo imaging using rare-earth nanocrystals with near-infrared to near-infrared (NIR-to-NIR) upconversion luminescence and magnetic resonance properties10.1016/j.biomaterials.2010.01.040 ↗
40. Facile fabrication of hollow mesoporous Eu3+-doped Gd2O3 nanoparticles for dual-modal imaging and drug delivery10.1016/j.dyepig.2015.07.015 ↗
41. Combined optical and MR bioimaging using rare earth ion doped NaYF4 nanocrystals10.1002/adfm.200800765 ↗
42. Hollow structured Y2O3:Yb/Er-CuxS nanospheres with controllable size for simultaneous chemo/photothermal therapy and bioimaging10.1021/cm503647k ↗
43. Up-conversion Y2O3:Yb3+,Er3+ hollow spherical drug carrier with improved degradability for cancer treatment10.1021/acsami.6b07215 ↗
44. Microemulsion-made gadolinium carbonate hollow nanospheres showing magnetothermal heating and drug release10.1039/C7NR01784G ↗
45. Facile one-pot synthesis of carbon/calcium phosphate/Fe3O4 composite nanoparticles for simultaneous imaging and pH/NIR-responsive drug delivery10.1039/C6CC05515J ↗
46. Porous microspheres of magnesium whitlockite and amorphous calcium magnesium phosphate: microwave-assisted rapid synthesis using creatine phosphate, and application in drug delivery10.1039/C5TB01106J ↗
47. Calcium phosphate nanocapsule crowned multiwalled carbon nanotubes for pH triggered intracellular anticancer drug release10.1039/C5TB00534E ↗
48. Biodegradable calcium phosphate nanoparticle with lipid coating for systemic siRNA delivery10.1016/j.jconrel.2009.11.008 ↗
49. Hybrid mesoporous silica-based drug carrier nanostructures with improved degradability by hydroxyapatite10.1021/nn507485j ↗
50. Hydroxyapatite particles as a controlled release carrier of protein10.1016/j.biomaterials.2003.10.081 ↗
51. Bioactive, luminescent and mesoporous europium-doped hydroxyapatite as a drug carrier10.1016/j.biomaterials.2008.07.042 ↗
52. Freeze-dried cationic calcium phosphate nanorods as versatile carriers of nucleic acids (DNA, siRNA)10.1039/C1JM13502C ↗
53. The photoluminescence, drug delivery and imaging properties of multifunctional Eu3+/Gd3+ dual-doped hydroxyapatite nanorods10.1016/j.biomaterials.2011.08.032 ↗
54. Multifunctional Eu3+/Gd3+ dual-doped calcium phosphate vesicle-like nanospheres for sustained drug release and imaging10.1016/j.biomaterials.2012.05.059 ↗
55. Structural insights in Dy3+-doped β-tricalcium phosphate and its multimodal imaging characteristics10.1111/jace.14714 ↗